Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002064832-26-000143
Filing Date
2026-03-13
Accepted
2026-03-13 16:20:56
Documents
1
Period of Report
2026-03-11

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 3887
  Complete submission text file 0002064832-26-000143.txt   5318
Mailing Address 4 KINGSBURY AVENUE WATERTOWN MA 02472
Business Address 4 KINGSBURY AVENUE WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Issuer) CIK: 0001177648 (see all company filings)

EIN.: 043205099 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ENANTA PHARMACEUTICALS, INC. 500 ARSENAL STREET WATERTOWN MA 02472
Business Address
Vance Terry (Reporting) CIK: 0001572282 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35839 | Film No.: 26752771